- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-11-0011699

Udai Pharmaceuticals Private Limited
About Udai Pharmaceuticals Private Limited
Data last updated:
Udai Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 15 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2020PTC371581. Its GSTIN is 07AACCU6957H1ZY (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Samar Bahadur and Amar Bahadur Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 1 1st Floor DLF Ind. Area Najafgarh Road, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.43 Cr, a growth of 75% compared to the previous year. For the same year it recorded a net profit of ₹3.25 Lakh (net margin 2.3%) and EBITDA of ₹5.61 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years.
Udai Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0011699).
Company details
Recognitions & Rankings of Udai Pharmaceuticals
Contact details
Udai Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No. 1 1st Floor DLF Ind. Area Najafgarh Road, Delhi, India – 110015
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Udai Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Udai Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Udai Pharmaceuticals Private Limited, buy the company report.
Financials of Udai Pharmaceuticals Private Limited
FY 2025 filings availableUdai Pharmaceuticals Private Limited reported revenue of ₹1.43 Cr (up 75% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 47% over three years, including 75% growth in the latest year. EBITDA rose 96% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.61 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Udai Pharmaceuticals Private Limited, buy the company report.
Board of directors of Udai Pharmaceuticals Private Limited
Udai Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Samar Bahadur | Director | 15 Oct 2020 | 6 Years 0 Months | Current |
| Amar Bahadur Yadav | Director | 15 Oct 2020 | 6 Years 0 Months | Current |
| Lalbahadur Also directs: Akminscare Pharmaceuticals Private Limited | Director | 15 Oct 2020 | 6 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Udai Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Udai Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Udai Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCU6957H1ZY | Delhi | Active | 30 Oct 2020 |
To see the full GST registrations and return filing status of Udai Pharmaceuticals Private Limited, buy the company report.
Recent activity
Udai Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Amar Bahadur Yadav was appointed as Director on 15 Oct 2020.
Frequently asked questions
Udai Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 15 October 2020 (6+ years old) and is registered under CIN U24239DL2020PTC371581.
Udai Pharmaceuticals has 3 current directors:
- Samar Bahadur - Director
- Amar Bahadur Yadav - Director
- Lalbahadur - Director
The latest financial statements of Udai Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Udai Pharmaceuticals is 07AACCU6957H1ZY, registered in Delhi.
The CIN (Corporate Identification Number) of Udai Pharmaceuticals is U24239DL2020PTC371581. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Udai Pharmaceuticals was incorporated on 15 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Amar Bahadur Yadav was appointed as Director on 15 Oct 2020. Lalbahadur was appointed as Director on 15 Oct 2020. Samar Bahadur was appointed as Director on 15 Oct 2020.
Yes, Udai Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0011699).
The registered office of Udai Pharmaceuticals is at House No. 1 1st Floor DLF Ind. Area Najafgarh Road, Delhi, India – 110015.
Udai Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

